What is the common treatment modality for nasal polyps?

Intranasal corticosteroids are considered the common treatment modality for nasal polyps due to their anti-inflammatory properties. These medications work by reducing inflammation in the nasal passages, which can decrease the size of the polyps and alleviate symptoms such as nasal obstruction and congestion.

Nasal polyps are essentially swollen tissue that occurs as a result of chronic inflammation, often associated with conditions like asthma, allergic rhinitis, and chronic sinusitis. By delivering corticosteroids directly to the nasal mucosa, they help manage the underlying inflammation that contributes to polyp formation. This treatment can lead to significant improvement in nasal airflow and overall quality of life for patients.

While other treatment options exist, such as oral antibiotics for associated infections, surgical interventions for larger or persistent polyps, and antihistamines for allergy symptoms, intranasal corticosteroids remain the first-line therapy due to their effectiveness in directly targeting the inflammation that causes polyps.